Jin Rong Jie Zi Xun·2025-12-26 04:58Core Insights - JD Health and Love Health signed a strategic cooperation agreement for 2026, aiming to enhance collaboration in the healthcare supply chain, digital marketing innovation, user service experience, and project incubation in the sexual health industry [1][3] Group 1: Strategic Partnership - The partnership focuses on "co-building high growth" by leveraging resource advantages to drive the sexual health industry towards professionalism and digitization [1] - JD Health has become the launch platform for new strategic products from Love Health, indicating a strong collaborative relationship [3] Group 2: Marketing and Product Performance - Since 2025, both companies have engaged in deep marketing cooperation, utilizing a "breakthrough products + scenario penetration" model to stimulate consumer enthusiasm and expand brand presence [3] - The Durex brand, under Love Health, launched the Durex Super Thin 003 delay condom on JD's platform, achieving over 10 million sales within a month, setting an industry benchmark [3] - In the lubricant category, Durex leads with a comprehensive medical product line, with hyaluronic acid lubricants seeing over 20% year-on-year growth and female pleasure liquids growing over 30%, meeting market demand for safe and comfortable health products [3] - Durex's delay spray and wet wipes also demonstrated strong market competitiveness, with a 95% year-on-year increase in sales, gaining consumer favor [3] Group 3: Future Directions - The signing of the strategic cooperation agreement marks a significant milestone for both companies, with plans to continue driving product innovation and exploring the integration of smart technology in health and lifestyle [3]